
Serum Alkaline Phosphatase and Mortality in African Americans with Chronic Kidney Disease
Author(s) -
Srinivasan Beddhu,
Xiulian Ma,
Bradley C. Baird,
Alfred K. Cheung,
Tom Greene
Publication year - 2009
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.01560309
Subject(s) - medicine , interquartile range , hazard ratio , kidney disease , alkaline phosphatase , renal function , endocrinology , population , confidence interval , proportional hazards model , gastroenterology , biochemistry , biology , environmental health , enzyme
Serum alkaline phosphatase has been associated with increased mortality in hemodialysis patients but its associations with mortality in chronic kidney disease (CKD) stages III and IV are unknown. Design, settings, participants & measurements: In 1094 participants in the African-American Study of Kidney Disease and Hypertension (AASK) database, the associations of serum alkaline phosphatase with mortality and cardiovascular events were examined in Cox models.